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A 51-year-old man with primary hyperparathyroidism was re-
ferred for radionuclide localization of hyperfunctioning parathyroid 
glands. He was complaining of weakness, nausea, excessive urina-
tion, and occasional heart palpitations. Laboratory values were the 
following: elevated parathyroid hormone level 184 pg/ml (normal 
Figure 2. Maximum intensity projection PET (Biograph 64, Siemens, 
Germany) performed 60 minutes after injection of 200 MBq of F-18-
Choline, revealed two foci of increased radiotracer uptake (arrows) 
localized bilaterally in the lower neck. The image showed multiple focal 
lesions of increased activity in the ribs and the right scapula resulting 
from the disease
Figure 1. Tc-99m-sodium pertechnetate planar image (Symbia 
TruePoint T-16 SPECT/CT scanner, Siemens, Germany) acquired 20 
minutes after injection of 111MBq of radiopharmaceutical (A). Tc-99m-
MIBI planar scan obtained 15 minutes after injection of 370 MBq of 
radiopharmaceutical did not reveal any foci of increased uptake (B). 
Subtraction image without areas of abnormal uptake (C). An axial scan 
of Tc-99m-MIBI SPECT/CT performed after planar acquisition, negative 
for hyperfunctioning parathyroid glands (D)
range, 14–72 pg/ml), hypercalcemia–a calcium level of 11.1 mg/dl 
(normal range, 8.7–10.4 mg/dl) and normal renal parameters. Cervi-
cal ultrasonography and contrast enhanced computed tomography 
(CT) of the neck were negative. Early Tc-99m-methoxyisobutylisoni-
trile (MIBI) images, Tc-99m-MIBI/Tc-99m-sodium pertechnetate 
subtraction and Tc-99m-MIBI single photon emission computed 
tomography (SPECT)/CT failed to identify a focal area of increased 
uptake. F-18-Deoxyglucose positron emission tomography (PET)/ 
/CT was also negative. F-18-Choline PET/CT demonstrated two foci 
of increased radiotracer uptake localized behind the lower poles of 
the thyroid gland consistent with hyperfunctioning parathyroid 
glands. The patient underwent excision of these two bilateral le-
sions and the subsequent pathology examination confirmed the 
presence of parathyroid hyperplasia. The parathyroid hormone 
and calcium level normalized after the surgery. In the presented 
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case, abnormal parathyroid glands were correctly localized by 
F-18-Choline PET/CT, whereas conventional Tc-99m-MIBI scintigra-
phy was false negative. The results of few recent studies and case 
reports suggest the usefulness of F-18-Choline PET/CT in imaging 
of the hyperfunctioning parathyroid tissue, particularly when mul-
tiple lesions occur. Further research is necessary to evaluate the 
diagnostic performance of this radiopharmaceutical for localization 
of parathyroid hyperplasia or adenoma.
Figure 3. A. Axial scan of F-18-Choline PET/CT demonstrated two foci 
(arrows) of markedly increased uptake localized posteriorly to both 
inferior parts of the thyroid lobes; B. Hyperfunctioning parathyroid 
glands on CT axial scan (arrows), the diameters of the glands 
were: 4x4mm on the right side and 8 × 5mm on the left; C. F-18-
Deoxyglucose PET/CT scan was negative for abnormal uptake in this 
region
